CHMJF (CHMJF) Stock Price & Analysis
CHMJF (CHMJF) rose 0.00% to USD 0.02 as of July 25, 2026 at 13:09 UTC, according to Nexqual real-time market data.
CHMJF last closed at USD 0.02; the session ranged USD 0.1–0.1 on volume of 13 shares. Market capitalization is $226,815, with a 52-week range of USD 0.02–0.14 (PNK). Source: Nexqual, July 25, 2026 at 13:09 UTC.
Key Statistics (as of July 25, 2026 at 13:09 UTC)
| Price | USD 0.02 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0.02 |
| Open | USD 0.1 |
| Day Range | USD 0.1 – 0.1 |
| 52-Week Range | USD 0.02 – 0.14 |
| Volume | 13 shares |
| Market Cap | $226,815 |
| Exchange | PNK |
Technical Analysis (CHMJF)
Nexqual's technical model rates CHMJF "SELL" based on 2 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 13:09 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0.02) |
| MACD | -0 (negative) |
Analyst Ratings (CHMJF)
Wall Street analysts rate CHMJF "None", per Nexqual as of July 25, 2026 at 13:09 UTC.
| Consensus Rating | None |
|---|
Earnings (CHMJF)
Source: Nexqual, July 25, 2026 at 13:09 UTC.
Financials & Fundamentals (CHMJF)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| Current Ratio | 0.21 |
| Total Cash | $72,254 |
| Total Debt | $443,959 |
| Free Cash Flow | $-320,425 |
Source: Nexqual, July 25, 2026 at 13:09 UTC.
Financial Health Score (CHMJF)
Nexqual rates CHMJF's overall financial health "Weak" across five dimensions, as of July 25, 2026 at 13:09 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Gross margin 0%, operating 0% |
| Balance Sheet | Mixed — $72K cash, no debt |
| Cash Flow | Weak — Operating cash flow -$412K |
| Efficiency | Mixed — No data |
Ownership (CHMJF)
| Insider Ownership | +18.17% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 9.86M |
| Float | 8.81M |
Source: Nexqual, July 25, 2026 at 13:09 UTC.
Leadership (CHMJF)
CHMJF is led by Douglas Edward Ford (age 62), CEO & Director, per Nexqual as of July 25, 2026 at 13:09 UTC.
| CEO & Director | Douglas Edward Ford (age 62) |
|---|---|
| CFO & Secretary | Elbert Yow Wong |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BIOIF | BIOME GROW INC | USD 0 | ▲ 0% |
| BBRRF | Blueberries Medical Co. | USD 0.01 | ▼ 16.67% |
| SRUTF | SPROUTLY CANADA INC | USD 0 | ▲ 0% |
| KHRNF | KHIRON LIFE SCIENCES CORP | USD 0 | ▲ 0% |
| DVLP | GOLDEN DEVELOPING SOLUTIONS INC | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 13:09 UTC. This page is informational and not investment advice.